A quantitative study of daytime sleepiness induced by carbamazepine and add-on vigabatrin in epileptic patients

Acta Neurologica Scandinavica

Volumn 95, Issue 4, 1997, Pages 193-196

  Bonanni, E ^a   Massetani, R ^a   Galli, R ^a   Gneri, C ^a   Petri, M ^a   Iudice, A ^a   Murri, L ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

carbamazepine; daytime sleepiness; epilepsy; multiple sleep latency test; vigabatrin

Indexed keywords

CARBAMAZEPINE; VIGABATRIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; SLEEP PATTERN; SLEEP TIME; SOMNOLENCE;

EID: 0030942593     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0404.1997.tb00097.x     Document Type: Article

References (27)

1. Collaborative Group for Epidemiology of Epilepsy. Adverse reactions to antiepileptic drugs: a multicenter survey of clinical practice. Epilepsia 1986: 27: 323-30.
2. MANNI R, RATTI MT, PERUCCA E et al. A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study. Electroencephalogr Clin Neurophysiol 1993: 86: 322-8.
3. DODRILL CB. Effects of antiepileptic drugs on abilities. J Clin Psychiatry 1988: 49(Suppl 4): 31-4.
4. AIKIA M, KALVIAINEN R, SIVENIUS J et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992: 11: 199-203.
5. FENWICK PBC. The relationship between mind, brain, and seizures. Epilepsia 1992: 33(Suppl 6): 1-6.
6. MEADOR KJ, LORING DW, HUH K et al. Comparative cognitive effects of anticonvulsants. Neurology 1990: 40: 391-4.
7. KERANEN I, SIVENIUS J. Side effects of carbamazepine, valproate and clonazepam during long-term treatment of epilepsy. Acta Neurol Scand 1983: 68(Suppl 97): 69-80.
8. THOMPSON PJ, TRIMBLE MR. Anticonvulsant serum levels: relationship to impairments of cognitive funtioning. J Neurol Neurosurg Psychiat 1983: 46: 227-33.
9. PERUCCA E, RICHENS A. Antiepileptic drugs. Clinical aspects. In: RICHENS A, MARKS V, eds. Therapeutic Drug Monitoring. Edinburgh: Churchill-Livingstone, 1981: 320-48.
10. SMITH DB, CRAFT BR, COLLINS J et al. Behavioural characteristics of epilepsy patients compared with normal controls. Epilepsia 1986: 27: 753-9.
11. RICHARDSON GS, CARSKADON MA, ORAV EJ et al. Circadian variation of sleep tendency in elderly and young adult subjects. Sleep 1982: 5: 82-94.
12. MANNI R, RATTI MT, GALIMBERTI CA et al. Daytime sleepiness in epileptic patients on long-term monotherapy: MSLT, clinical and psychometric assessment. Neurophysiol Clin 1993: 23: 71-6.
13. MURRI L, MASSETANI R, KRAUSE M et al. Evaluation of antihistamine-related daytime sleepiness. Allergy 1992: 47: 532-4.
14. CARSKADON MA, DEMENT WC, MITLER MM, ROTH T, WESTBROOK PR, KEENAN S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986: 9: 519-24.
15. CHERVIN RD, KRAEMER HC, GUILLEMINAULT C. Correlates of sleep latency on the multiple sleep latency test in a clinical population. Electroencephalogr Clin Neurophysiol 1995: 95: 147-53.
16. PALM L, ANDERSON H, ELMQVIST D, BLENNOW G. Daytime sleep tendency before and after discontinuation of antiepileptic drugs in preadolescent children with epilepsy. Epilepsia 1992: 33: 687-91.
17. HODDES E, ZARCONE V, SMYTHE H. Quantification of sleepiness: a new approach. Psychophysiology 1993: 10: 431-6.
18. RECHSTCHAFFEN A, KALES A. A manual of standardised terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service, Brain Research Institute, UCLA, 1968.
19. CONOVER WJ, IMAN RL. Rank transformation as a bridge between parametric and non-parametric statistics. Am Statistician 1981: 35: 124-9.
20. SAS Institute Inc. SAS/STAT User's guide, release 6.03 edition. Cary, NC, 1988.
21. REYNOLDS EH. Neurotoxicity of carbamazepine. In: PENRY JK, DALY DD, eds. Advances in Neurology: Complex partial seizures and their treatment. New York: Raven Press, 1975: 403-31.
22. GALLASSI R, MORREALE A, LORUSSO S et al. Carbamazepine and phenytoin. Comparison of cognitive effects in epileptic patients during monotherapy and withdrawal. Arch Neurol 1988: 45: 892-4.
23. GILLHAM RA, WILLIAMS N, WIEDMANN KD et al. Cognitive function in adult epileptic patients established on anticonvulsant monotherapy. Epilepsy Res 1990: 7: 219-25.
24. BENOIT O, FORET J. Régulation circadienne des états de veille et de sommeil. Neurophysiol Clin 1988: 18: 403-31.
25. LEVY A, CHONG SKF, PRICE JF. Carbamazepine-induced drowsiness. Lancet 1985: ii: 221-2.
26. GILLHAM RA, BLACKLAW J, MCKEE PJW et al. Effect of vigabatrin on sedation and cognitive function in patients with refractory epilepsy. J Neurol Neurosurg Psychiat 1993: 56: 1271-5.
27. GRANT SM, HEEL RC.Vigabatrin. Drugs 1991: 41: 889-926.